CA-YOKOGAWA-ELECTRIC
25.3.2022 06:02:12 CET | Business Wire | Press release
Yokogawa Electric Corporation (TOKYO: 6841) announces that it has successfully completed a proof of concept test of technology that reduces energy consumption and stabilizes the quality of the water discharged by the Tapia Water Reclamation Facility of the Las Virgenes Municipal Water District (LVMWD), located in Los Angeles County, California. This initiative was undertaken as part of the company’s proposal to improve the performance of existing wastewater reclamation facilities in conjunction with a program sponsored by the Japan Ministry of Economy, Trade and Industry that seeks to examine opportunities for the overseas deployment of high quality energy infrastructure.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220324006055/en/
Water stress is an increasingly pressing issue worldwide due to the effects of climate change and the rising demand for water driven by population growth. In order to ensure stability in water resources, more and more countries are looking to make proactive use of reclaimed water. In the USA, the state of California is considering changes in regulations*1 that will allow the direct use of reclaimed water for drinking water by the end of 2023, and this is the subject of serious discussions and cooperation between the public and private sectors.
This proof of concept was conducted as part of the Pure Water Project and led by the LVMWD, whose aim is to produce potable water from highly treated wastewater in compliance with State water quality standards. Doing so required LVMWD to consider alternative technological approaches, as treating water to potable quality consumes enormous amounts of electricity and is more maintenance intensive. Yokogawa has been studying ways to address such challenges by making use of the company’s extensive process knowledge and experience in monitoring and control of industrial facilities.
Given the large fluctuations in the quality of the wastewater that flows into reclamation facilities, plant operators must take proper care while monitoring the inflow rate to ensure that the mandated water quality standards are met, and rely on their knowledge and technical expertise to make the necessary adjustments. Yokogawa applied its advanced data driven modeling for optimization (DDMO) software suite to model and then predict setpoints to optimize operations and support operator decision making while maintaining the targeted water quality at water treatment facilities.
As this proof of concept was conducted during the COVID-19 pandemic, Yokogawa used its Yokogawa Cloud platform to minimize the site activities and move site data to Japan where the DDMO software utilized real-time operational data to derive control setpoints that were sent back to operators at the Tapia Water Reclamation Facility. After conducting a multifaceted evaluation and performing a concrete verification of effectiveness, it was revealed that improvements in operational efficiency had yielded an over 10% reduction in power consumption, while meeting all water quality standards. Impressed with these results, the WateReuse Association presented Yokogawa and its partners with a 2022 Transformational Innovation award*2 .
Tsuyoshi Abe, a Yokogawa Electric vice president and head of the Marketing Headquarters, says, “Water is a public asset and a finite resource. Goal 6 of the SDGs is to ‘Ensure access to water and sanitation for all,’ and this is an important area where Yokogawa can contribute. Toward this end, the effective utilization of reclaimed water as a sustainable water source for communities is a groundbreaking approach. The efficient purification and provision of safe and secure drinking water requires the understanding of all stakeholders and a lot of revolutionary technology. In order to build a circular ecosystem for water resources and create new value, we will work to further strengthen our collaboration with partners to drive forward co-innovation, and utilizing our capabilities to measure and connect, we will fulfill our responsibilities for the future of our planet.”
*1 The California Water Boards: Regulating direct potable reuse in California
https://www.waterboards.ca.gov/drinking_water/certlic/drinkingwater/direct_potable_reuse.html
*2 WateReuse Awards for Excellence, Transformational Innovation award, presented at the 37th Annual WateReuse Symposium. Award recipients: Yokogawa Electric Corporation, Las Virgenes Municipal Water District, Carollo Engineers, the National Water Research Institute, Metropolitan Water District, Bureau of Reclamation, IOSight
https://watereuse.org/news-events/awards/past-award-winners/watereuse-award-winners-2022/
About Yokogawa
Yokogawa provides advanced solutions in the areas of measurement, control, and information to customers across a broad range of industries, including energy, chemicals, materials, pharmaceuticals, and food. Yokogawa addresses customer issues regarding the optimization of production, assets, and the supply chain with the effective application of digital technologies, enabling the transition to autonomous operations.
Founded in Tokyo in 1915, Yokogawa continues to work toward a sustainable society through its 17,500 employees in a global network of 119 companies spanning 61 countries.
For more information, visit www.yokogawa.com
The names of corporations, organizations, products, services and logos herein are either registered trademarks or trademarks of Yokogawa Electric Corporation or their respective holders.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220324006055/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
vVARDIS Announces Investment from Apollo—Achieves Unicorn Status27.4.2026 14:51:00 CEST | Press release
Investment will support global commercial expansion of the Curodont™ technology platform, the first and only non-invasive peptide-containing formulations designed to treat tooth decay drill-free throughout the depth of the lesion vVARDIS Holding AG (“vVARDIS”), a high-growth dental medtech company pioneering non-invasive cavity treatment, today announced a strategic minority investment from Apollo-managed funds (“Apollo Funds”). The investment will support vVARDIS’ next phase of global growth and commercial expansion, including the continued rollout of its Curodont™ suite of products. The investment establishes vVARDIS as one of Europe’s few privately owned, billion-dollar-plus, healthcare companies. vVARDIS’ founders and co-CEOs, Drs. Haley and Goly Abivardi, will retain a substantial majority shareholding in the company. vVARDIS is redefining the treatment of cavities through its Curodont™ technology, the first and only commercially available non-invasive peptide-containing formulati
IAS Launches IAS Total TV Solutions Giving Marketers ‘Linear-like’ Transparency for Connected TV27.4.2026 14:30:00 CEST | Press release
‘IAS Total TV’ unlocks show, genre and rating transparency measurement across Disney, NBCUniversal, Paramount and Prime Video, plus multiple opted-in publishers using Publica enabling advertisers to enhance brand suitability while increasing campaign outcomes Integral Ad Science (IAS) today announced ‘IAS Total TV’, a new comprehensive suite of Connected TV (CTV) solutions designed specifically to bring ‘linear-like’ transparency to streaming TV. IAS Total TV can provide marketers with genre, rating, language, show and program-level data in aggregate from Disney, NBCUniversal, Paramount and Prime Video, in addition to multiple opted-in publishers using Publica. IAS Total TV integrates content insights, media quality, supply path and outcomes into a unified view within the IAS Signal user interface (UI). Advertisers can determine when and how they want their advertising to run alongside CTV content, ensuring brand-related and brand suitable environments. “As advertisers continue to doub
Riskified Study Finds Consumers Aren’t Ready to Hand Over Control as AI Transforms Shopping, with Over Half Afraid of Online Fraud27.4.2026 14:00:00 CEST | Press release
New Q1 2026 “Agentic Commerce Pulse” survey from Riskified reveals a growing trust gap in agent-driven commerce, as consumers embrace AI across the shopping journey but remain hesitant to hand over control amid concerns over fraud, security, and accountability Riskified (NYSE: RSKD), a global leader in ecommerce fraud and risk intelligence, today released the Q1 2026 edition of its Agentic Commerce Pulse, a quarterly research series tracking agentic commerce risks and consumer engagement. Following Riskified’s inaugural Q4 2025 survey, which first highlighted the rapid emergence of agent-driven commerce, the latest findings reveal a more complex reality: while AI adoption remains strong, consumer trust is not keeping pace. A widening gap is emerging between how shoppers use AI and how much control they are willing to give it. The survey, conducted among consumers across the United States and the United Kingdom, shows that AI is now firmly embedded in product discovery and decision-maki
Nine in 10 Expect Cross-Border M&A Surge, But 71% of Dealmakers Have Already Changed Course on Deals27.4.2026 14:00:00 CEST | Press release
90% of dealmakers expect cross-border M&A activity to increase over the next 12–24 months75% cite foreign direct investment screening as the biggest threat to deal completion88% report longer signing-to-close timelines than three years ago Cross-border M&A is set for a strong resurgence, with nine in 10 senior dealmakers expecting activity to increase over the next 12 to 24 months, according to new research from CSC, the leading provider of business administration and compliance solutions. However, despite this renewed momentum, execution risk is rising, with regulatory scrutiny and operational challenges making it harder to get deals over the line. CSC¹ surveyed 200 director level and above global dealmakers across private equity, corporate, legal, and advisory roles who have worked on cross-border transactions in the past two years. The report, The New Reality of Cross-Border M&A: More Deals, More Friction, explores how firms are navigating an increasingly complex global deal environ
Mundipharma announces positive topline results from Phase III ReSPECT trial assessing ▼REZZAYO® (rezafungin) for the prophylaxis of invasive fungal diseases in allogeneic haematopoietic stem cell transplantation patients27.4.2026 13:43:00 CEST | Press release
For Trade and Medical Media Only The study primary endpoint was met, showing non-inferiority vs. standard antimicrobial regimen in fungal-free survival at Day 90 Study showed favourable benefit for toxicity-related discontinuations and drug-drug interactions (DDIs) Rezafungin was well tolerated, with a safety profile comparable to standard antimicrobial regimens (SARs) Mundipharma today announced positive Phase III topline results from the global ReSPECT clinical trial evaluating REZZAYO® (rezafungin acetate) for prophylaxis of invasive fungal diseases (IFDs) in adult patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT). The ReSPECT Phase III trial, one of the largest antifungal, multicentre, randomised, double-blind studies evaluated the efficacy and safety of once weekly rezafungin compared with a SAR for the prophylaxis of IFDs, including infections caused by Candida, Aspergillus, and Pneumocystis, in adults undergoing allogeneic HSCT. Patients undergoing a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
